ライフサイエンスコーパス: contraception

1 d relevant healthcare conditions (e.g., male contraception).

2 nsistently associated with the use of modern contraception.

3 ospermia and a possible drug target for male contraception.

4 velopments in both infertility treatment and contraception.

5 ult in increased subsequent use of effective contraception.

6 n, and 222 women used no method of long-term contraception.

7 ted with adverse changes in the provision of contraception.

8 in controlled release dosage forms used for contraception.

9 xposures: Use of different types of hormonal contraception.

10 for combination HIV prevention and hormonal contraception.

11 ce: Millions of women worldwide use hormonal contraception.

12 pplication, for example in endometriosis and contraception.

13 ations for human infertility and post-coital contraception.

14 eeding and as an important component of oral contraception.

15 who were neither pregnant nor using hormonal contraception.

16 son, and site, while accounting for time off contraception.

17 ially in those adolescents who may also need contraception.

18 any, iPLEDGE was their first introduction to contraception.

19 ovides a promising approach to hormonal male contraception.

20 using either nonhormonal contraception or no contraception.

21 ad compound targeting the male germ cell for contraception.

22 mate the effect of satisfying unmet need for contraception.

23 d be avoided by fulfilment of unmet need for contraception.

24 makes them ideal pharmaceutical targets for contraception.

25 al acetate with levonorgestrel for emergency contraception.

26 ight gain, and obesity, as well as emergency contraception.

27 sensitivity in the only woman using hormonal contraception.

28 nnually occur among the 90% of women who use contraception.

29 ld have profound effects on reproduction and contraception.

30 d to find ways to improve the use of regular contraception.

31 predictors of reversibility of hormonal male contraception.

32 tinib should be advised to practice adequate contraception.

33 pregnancies could be prevented by emergency contraception.

34 ns were observed for other forms of hormonal contraception.

35 a model for studies of male infertility and contraception.

36 ocyte maturation as a potential strategy for contraception.

37 ty, and for generating novel methods of male contraception.

38 gful increase in subsequent use of effective contraception.

39 m head shaping and potential target for male contraception.

40 ntifying the lowest dose required to achieve contraception.

41 ong women receiving levonorgestrel emergency contraception.

42 nintended pregnancies after use of emergency contraception.

43 sers and control subjects not using hormonal contraception.

44 , pregnancy incidence, and mean time without contraception.

45 by this policy are also providers of modern contraception.

46 uterine fibroids, endometriosis) as well as contraception.

47 vious year, and to report no use of hormonal contraception.

48 compared with those who never used hormonal contraception.

49 ide attempt and suicide in users of hormonal contraception.

50 who were neither pregnant nor using hormonal contraception (11 incident infections per 103 person-yea

51 n pregnant women who were not using hormonal contraception (18 incident infections per 423.5 person-y

52 CI 6.41-20.63) than women using no long-term contraception (3.71 per 100 person-years, 1.36-8.07; adj

53 who were neither pregnant nor using hormonal contraception (35 incident infections per 529.5 person-y

54 lization (49.8; 95% CI, 11.9-209.2), or oral contraception (43.0; 95% CI, 15.5-119.3 in women).

55 n 120 million couples have an unmet need for contraception, 80 million women have unintended pregnanc

56 judged possibly related to use of emergency contraception; a case of dizziness in the ulipristal ace

57 couples in which women did not use hormonal contraception (adjusted hazard ratio 1.97, 95% CI 1.12-3

58 Whether or not the use of hormonal contraception affects risk of HIV acquisition is an impo

59 Unless women start effective contraception after oral emergency contraception, they r

60 me." No women reported having used emergency contraception after unprotected sex.

61 opausal hormone replacement therapy and oral contraception, also stimulates growth of regressing xeno

62 and demand satisfied with modern methods of contraception among women of reproductive age who are ma

63 ears in couples in which women used hormonal contraception and 1.51 per 100 person-years in couples i

64 100 person-years in women who used hormonal contraception and 3.78 per 100 person-years in those who

65 of potential targets for germ cell-directed contraception and a staggering number of candidate prote

66 and reproductive health services, including contraception and abortion care, and for additional inve

67 ision of counselling on long-term reversible contraception and access to devices during family planni

68 receive advice to use long-acting reversible contraception and avoid pregnancy for a minimum of 1 yea

69 by providing access to and information about contraception and by reducing socioeconomic obstacles to

70 ardize the current approach to hormonal male contraception and call for more effective means of inhib

71 indicated that associations between hormonal contraception and depressive symptoms were stable.

72 ception, particularly long-acting reversible contraception and dual method contraceptive use; message

73 Provision of ongoing contraception and encouragement of emergency contracepti

74 Expanding access to contraception and ensuring that need for family planning

75 velopment of therapeutic modalities for both contraception and fertility.

76 hormonally dependent diseases, hormonal male contraception and growth inhibition of extra-pituitary c

77 pulation of European descent that proscribes contraception and has large family sizes.

78 limited schooling, minimal access to modern contraception and healthcare, and gendered inequalities

79 factors for stroke in women, including oral contraception and hormone therapy, and pregnancy-associa

80 egnancies, such as availability of effective contraception and induced abortion, vary over time, then

81 od, associations between the use of hormonal contraception and mood disturbances remain inadequately

82 show alpha4 as an attractive target for male contraception and open the possibility for the potential

83 lications in women's health, such as in oral contraception and post-menopausal hormone therapy.

84 hallenges, as well as specific needs such as contraception and pregnancy in female patients.

85 mented, facilitating studies of intrauterine contraception and reproductive tract infection.

86 s suggest null associations between hormonal contraception and risk of female-to-male HIV transmissio

87 ssociation between various forms of hormonal contraception and risk of HIV acquisition.

88 regnancies, but little is known about use of contraception and risk of unintended pregnancy in this p

89 ion at no cost and educated about reversible contraception and the benefits of LARC methods had rates

90 edroxyprogesterone acetate (DMPA) injectable contraception and the prevalence of periodontal diseases

91 sed associations between the use of hormonal contraception and the risk of invasive breast cancer in

92 -only contraceptives, 43 used other forms of contraception, and 222 women used no method of long-term

93 ose, 842 million (95% UI 800-893) use modern contraception, and 270 million (95% UI 246-301) have unm

94 f beliefs and behaviors regarding education, contraception, and animal domestication.

95 Women often have limited access to contraception, and barrier methods have low acceptance a

96 them), stillbirths averted, palliative care, contraception, and child physical and intellectual growt

97 tly more consistent use of condoms, hormonal contraception, and dual-method contraception than the co

98 cents, discuss the most effective methods of contraception, and ensure confidentiality from their par

99 ucts; used a reliable, non-barrier method of contraception, and had no visible or reported sexually t

100 three outcomes: sexual activity, demand for contraception, and modern contraceptive use.

101 in prevalence of sexual activity, demand for contraception, and modern contraceptive use.

102 his review are pain and the menstrual cycle, contraception, and preconception counseling.

103 Proactive management of mental illness, contraception, and pregnancy improves a woman's capacity

104 ying patients, providing abortion for failed contraception, and prescribing birth control to adolesce

105 bout alleviating climacteric symptoms, using contraception, and preventing diseases such as osteoporo

106 e at sexual health clinics, use of emergency contraception, and sexual function).

107 a method, vaginal barrier methods, emergency contraception, and standard days method.

108 ; (2) women beyond reproductive age or using contraception; and (3) all women.

109 s suggest that this autonomic method of male contraception appears free of major physiological and be

110 Therapeutic targets for male contraception are associated with numerous problems due

111 ctive health clinic, in which all methods of contraception are available, would result in increased s

112 in, additional pregnancy, and progestin-only contraception are potential modifiable factors that incr

113 men and women beyond reproductive age or on contraception are started on or switched to DTG-based AR

114 prevalent types of hormones associated with contraception are synthetic estrogens and progestins.

115 The role of hormonal contraception as a risk factor deserves further investig

116 or Disease Control categorizes every form of contraception as Category 2-benefits outweigh risks-in w

117 suicide were estimated for users of hormonal contraception as compared with those who never used horm

118 roviders are in a unique position to provide contraception, as they often intersect with women at the

119 Teenage girls and women who were provided contraception at no cost and educated about reversible c

120 ere provided with their choice of reversible contraception at no cost, and were followed for 2 to 3 y

121 Introduction of new forms of male contraception based on both hormonal and non-hormonal pa

122 l methods for safe, reliable, and reversible contraception based on the suppression of spermatogenesi

123 itamin K antagonists (VKAs) require adequate contraception because of the potential for fetal complic

124 ortance of discussing long-acting reversible contraception before and after pregnancy, to allow for a

125 In 203 women who received emergency contraception between 72 h and 120 h after sexual interc

126 pdated information about the use of hormonal contraception, breast-cancer diagnoses, and potential co

127 Women take oral contraceptives for contraception but also for menstrual dysfunction treatme

128 5.5-12.6 million) additional users of modern contraception by 2030 to meet the target of 75%.

129 found a symmetric reduction in use of modern contraception by 3.15 percentage points (relative decrea

130 Contraception can also improve perinatal outcomes and ch

131 Results show that contraception can be achieved with synthetic estrogen, w

132 Emergency contraception can prevent unintended pregnancies, but cu

133 The availability of modern contraception can reduce but never eliminate the need fo

134 contraception and encouragement of emergency contraception can reduce unintended pregnancies and the

135 rging as a promising therapeutic strategy in contraception, cancer, and heart disease.

136 1), largely due to fall in combined hormonal contraception (CHC; -15.0, -15.5 to -14.5, p < 0.001).

137 Data on use of hormonal contraception, clinical end points, and potential confou

138 dle patch for self-administered, long-acting contraception could enable women to better control their

139 se, long-lasting, injectable progestin-based contraception could mimic the high-progesterone luteal p

140 Satisfying unmet need for contraception could prevent another 104,000 maternal dea

141 Contraception counseling and provision are vital compone

142 To meet the unmet need for modern contraception, countries need to increase resources, imp

143 d 35 years and younger, excluding adjunctive contraception cycles, as the primary efficacy outcome me

144 rgely been driven by short-acting methods of contraception, despite the high effectiveness of long-ac

145 DMPA contraception does not increase vaginal mucosal CCR5(+)

146 Synthetic progesterone used in contraception drugs (progestins) can promote breast canc

147 f healthcare, some women might have obtained contraception elsewhere or had abortion procedure that w

148 Conclusions and Relevance: Use of hormonal contraception, especially among adolescents, was associa

149 1 acquisition and transmission with hormonal contraception, especially injectable methods, and about

150 Currently, three options for male-based contraception exist (i.e. withdrawal, condoms and vasect

151 Reproductive issues including contraception, fertility, and pregnancy are important co

152 f venous thromboembolism with newer hormonal contraception, few have examined thrombotic stroke and m

153 new agents to be used in female healthcare: contraception, fibroids, endometriosis, and certain brea

154 More women in the control group discontinued contraception for 1 to 2 weeks (N = 19, 13% versus N = 7

155 t cancer for every 7690 women using hormonal contraception for 1 year.

156 nylestradiol and 0.15 mg levonorgestrel) for contraception for at least 1 year were compared with 60

157 eders, they exhibited complete and permanent contraception for their entire reproductive lifespan, di

158 tent and correct use of effective methods of contraception for those youth who are or plan to be sexu

159 ducted for publications on the management of contraception for women with mental illness.

160 tent and correct use of effective methods of contraception for youth at risk of becoming pregnant.

161 priate, combined point estimates by hormonal contraception formulation using random-effects models.

162 of the progestogen-only pill with emergency contraception from a community pharmacist, along with an

163 Most women in the UK obtain emergency contraception from community pharmacies.

164 dy was the inability to separate women using contraception from those who were intending to conceive.

165 gies, we recruited 501 couples discontinuing contraception from two U.S. geographic regions from 2005

166 rtners in the past 3 months, use of hormonal contraception, having anal sex in the past 3 months, and

167 ng participants using long-acting reversible contraception (hazard ratio after adjustment for age, ed

168 s of a putative association between hormonal contraception (HC) and HIV acquisition have produced con

169 shows us that women currently using hormonal contraception (HC) have better scores on the Center for

170 er December, 2011, using the terms "hormonal contraception", "HIV/acquisition", "injectables", "proge

171 The primary outcome was the use of effective contraception (hormonal or intrauterine) at 4 months.

172 urgent need to develop new methods for male contraception, however a major barrier to drug discovery

173 elation to reproductive factors and hormonal contraception in a prospective cohort study of US Black

174 n of infection in pregnant women and funding contraception in epidemic regions.

175 r than 50% of women in need of FP use modern contraception in Senegal.

176 Tubal sterilization is a common form of contraception in the United States and is hypothesized t

177 ion between vasectomy, a common form of male contraception in the United States, and prostate cancer

178 es are the most popular reversible method of contraception in the United States.

179 women using low-efficacy contraception or no contraception, in models adjusted for propensity scores

180 t adolescent and young women will use modern contraception, including long-acting methods.

181 42 countries, and use of a modern method of contraception increased in 37 countries.

182 , with increases in 30 countries; demand for contraception increased in 42 countries, and use of a mo

183 id pregnancy and therefore needing effective contraception increased substantially, from 716 million

184 ogical research into whether use of hormonal contraception increases women's risk of HIV acquisition

185 he rate of failure of long-acting reversible contraception (intrauterine devices [IUDs] and implants)

186 , years of prostitution, workplace, hormonal contraception, intrauterine-device use, alcohol consumpt

187 of LH and FSH permits a feasible approach to contraception involving selective blockade of gonadotrop

188 immediate postpartum long-acting reversible contraception (IPP-LARC) separately from global payment

189 We provide evidence that use of contraception is a substantial and effective primary pre

190 is known about whether contemporary hormonal contraception is associated with an increased risk of br

191 Effective contraception is critical to young women with HIV-associ

192 Male hormonal contraception is efficacious, reversible and well tolera

193 Male hormonal contraception is highly effective, with perfect use fail

194 However, if hormonal emergency contraception is inadvertently taken in early pregnancy,

195 Ensuring that the need for contraception is met and that all abortions are safe wil

196 Effective contraception is particularly important for women with e

197 : To investigate whether the use of hormonal contraception is positively associated with subsequent u

198 y virus (HIV) transmission risk and hormonal contraception is sparse and conflicting.

199 inally, the mechanism of action of emergency contraception is still unknown, although studies continu

200 The effectiveness of long-acting reversible contraception is superior to that of contraceptive pills

201 childbearing, yet reasons for varying use of contraception itself remain insufficiently understood.

202 nd recommendations on long-acting reversible contraception (LARC) in the teen population, in order to

203 Long-acting reversible contraception (LARC) is among the most effective contrac

204 Long-acting reversible contraception (LARC), specifically intrauterine devices

205 adjusted for left truncation or time off of contraception (</= 2 months) before enrollment.

206 o indicate that hormonal strategies for male contraception may interfere with the blood-testis barrie

207 Hormonal contraception may reduce levels of depressive symptoms a

208 The widespread use of hormonal contraception may substantially increase the human S. au

209 Short-acting contraception methods (eg, oral contraceptives) can be u

210 n using injectable or long-acting reversible contraception methods (OCP 28% versus injectable/implant

211 uch as the subdermal implant or intrauterine contraception; most counseling focused on oral contracep

212 users compared with women using nonhormonal contraception (n = 23 per group).

213 contraceptive pills (n = 32), or no hormonal contraception (n = 33).

214 emale users of LARC and moderately effective contraception (n = 619).

215 trends in annual LARC and non-LARC hormonal contraception (NLHC) uptake and abortion rates, stratifi

216 6 years or older, not already using hormonal contraception, not on medication that could interfere wi

217 Oral contraception (OC) is used by approximately fifty-five m

218 We now report contraception of male nonhuman primates (Macaca radiata)

219 Participants were provided with reversible contraception of their choice at no cost.

220 o reducing stigma and meeting the demand for contraception of young women.

221 ted the effect of initiating use of hormonal contraception on cervical HSV detection.

222 linical evidence of an influence of hormonal contraception on some women's mood, associations between

223 The impact of hormonal contraception on time to HIV transmission from HIV-posit

224 d most commonly used for injectable hormonal contraception, on HSV type 1 (HSV-1) reactivation and CD

225 is occurs in subjects receiving estrogen for contraception or hormone replacement, or in susceptible

226 ause), exogenous sex hormones (e.g. hormonal contraception or hormone therapy) also may modulate migr

227 l: 0.14, 0.95) than women using low-efficacy contraception or no contraception, in models adjusted fo

228 tive women who were using either nonhormonal contraception or no contraception.

229 ith <10% in each arm selecting condoms, oral contraception, or intrauterine devices (IUDs).

230 Given the wide use of oestrogen (contraception, osteoporosis and menopause), more researc

231 tivariable analysis controlling for hormonal contraception, other STIs, behavioral, and demographic f

232 men (12.5%) after initiating use of hormonal contraception (P=.4).

233 itive evidence about the effects of hormonal contraception, particularly DMPA, on HIV risk.

234 e intervention group focused on promotion of contraception, particularly long-acting reversible contr

235 crease in PrEP uptake among women using oral contraception pills (OCPs) compared to women using injec

236 terim method of contraception with emergency contraception plus an invitation to a sexual and reprodu

237 ed by our sample is attributable to hormonal contraception (population-attributable fraction).

238 cy), or a reproductive factor in women (oral contraception, postmenopausal hormone therapy, or pregna

239 to examine relative changes in use of modern contraception, pregnancy, and abortion in response to th

240 ms included bariatric procedures, fertility, contraception, pregnancy, and nutritional deficiencies.

241 emale exposure to reproductive factors (oral contraception, pregnancy/puerperium, and postmenopausal

242 n mixed effects models adjusted for hormonal contraception/pregnancy, sexual risk-taking, and age, me

243 Only 35% had contraception prescribed within 12 months of becoming pr

244 Women discontinuing contraception provided daily first-morning urine specime

245 a-uterine systems for long-acting reversible contraception provides strong impetus to define immunomo

246 Additionally, new approaches to contraception remain elusive.

247 n-surgical methods of long-term or permanent contraception remains a challenge.

248 A pharmacologic approach to male contraception remains a longstanding challenge in medici

249 ining [NEET]; child marriage; and demand for contraception satisfied with modern methods).

250 Progress towards satisfying demand for contraception should take account of the changing contex

251 After cessation of male hormonal contraception, sperm output fully recovers in a predicta

252 Upon stopping contraception, subjects provided daily urine specimens a

253 users compared with women using nonhormonal contraception, suggesting that prevention efficacy is un

254 ly updated information about use of hormonal contraception, suicide attempt, suicide, and potential c

255 oms, hormonal contraception, and dual-method contraception than the control group.

256 with an effective alternative for emergency contraception that can be used up to 5 days after unprot

257 vide highly effective, reversible, long-term contraception that is appropriate for many women after f

258 pared with women who had never used hormonal contraception, the relative risk of breast cancer among

259 After discontinuation of hormonal contraception, the risk of breast cancer was still highe

260 was changed to those who never used hormonal contraception, the RR estimates for users of combined or

261 effective contraception after oral emergency contraception, they remain at risk of unintended pregnan

262 .26) and in the number of women using modern contraception to 918 million (95% UI 840-1,001).

263 8-50 years of age, use or willingness to use contraception to avoid pregnancy, and no obvious pelvic

264 A cohort of 501 couples who discontinued contraception to become pregnant was prospectively follo

265 , and what proportion of women use emergency contraception to try to prevent pregnancy.

266 age, lower education, long-acting reversible contraception usage, Trichomonas vaginalis infection, ba

267 m 743 691 women, country-year data on modern contraception use, and annual data on development assist

268 exual relationship, and history of effective contraception use, and was robust to the effect of missi

269 We empirically examined patterns of modern contraception use, pregnancies, and abortion among women

270 history of ovarian cancer, duration of oral contraception use, tubal ligation, gravidity, education,

271 data for modern contraceptive use by type of contraception used (long-acting, short-acting, or perman

272 The success rate of male hormonal contraception using injectable testosterone alone is hig

273 this approach, which we refer to as vectored contraception (VC).

274 ong all current and recent users of hormonal contraception was 1.20 (95% confidence interval [CI], 1.

275 The proportion of women using effective contraception was 20.1% greater (95% CI 5.2-35.0) in the

276 Despite this high knowledge, unmet need for contraception was also high: 31.7% (95%CI 27.9-35.7) amo

277 Use of emergency contraception was most commonly reported among black Car

278 Use of hormonal contraception was positively associated with subsequent

279 Emergency contraception was used by 113 (11.8%) of women who reque

280 Increases over time in met need for contraception were correlated with increases in gender e

281 , the proportions reporting use of emergency contraception were higher in young women than in older w

282 nutrition, fertility, cesarean delivery, and contraception were limited.

283 farction associated with the use of hormonal contraception were low, the risk was increased by a fact

284 Usual costs for contraception were maintained at all sites.

285 ditional pregnancy and use of progestin-only contraception were marginally associated with diabetes r

286 in maternal mortality if the unmet need for contraception were met, at country, regional, and world

287 icrobiome compositional subtype and hormonal contraception were significantly associated with genital

288 nts, we can see that they will use effective contraception when contraceptive services, including sho

289 efined as the proportion of women in need of contraception who were using a contraceptive method at t

290 female educational attainment and access to contraception will hasten declines in fertility and slow

291 en-only pill as a bridging interim method of contraception with emergency contraception plus an invit

292 l variation in the proportion of women using contraception with fractional logistic regression.

293 l first-in-class nonsteroidal PR agonist for contraception with improved safety and side effect profi

294 s treatment with MIS may provide a method of contraception with the unique characteristic of blocking

295 Participants were educated about reversible contraception, with an emphasis on the benefits of LARC

296 family planning clinic requesting emergency contraception within 5 days of unprotected sexual interc

297 le population, 1696 women received emergency contraception within 72 h of sexual intercourse (ulipris

298 egnancy rate in women who received emergency contraception within 72 h of unprotected sexual intercou

299 wo autocrine mechanisms essential to achieve contraception within our previous menstrual cycle models

300 h package, meeting 90% of the unmet need for contraception would reduce global births by almost 28 mi